AP-1 is a component of the transcriptional network regulated by GSK-3 in quiescent cells

PLoS One. 2011;6(5):e20150. doi: 10.1371/journal.pone.0020150. Epub 2011 May 25.

Abstract

Background: The protein kinase GSK-3 is constitutively active in quiescent cells in the absence of growth factor signaling. Previously, we identified a set of genes that required GSK-3 to maintain their repression during quiescence. Computational analysis of the upstream sequences of these genes predicted transcription factor binding sites for CREB, NFκB and AP-1. In our previous work, contributions of CREB and NFκB were examined. In the current study, the AP-1 component of the signaling network in quiescent cells was explored.

Methodology/principal findings: Using chromatin immunoprecipitation analysis, two AP-1 family members, c-Jun and JunD, bound to predicted upstream regulatory sequences in 8 of the 12 GSK-3-regulated genes. c-Jun was phosphorylated on threonine 239 by GSK-3 in quiescent cells, consistent with previous studies demonstrating inhibition of c-Jun by GSK-3. Inhibition of GSK-3 attenuated this phosphorylation, resulting in the stabilization of c-Jun. The association of c-Jun with its target sequences was increased by growth factor stimulation as well as by direct GSK-3 inhibition. The physiological role for c-Jun was also confirmed by siRNA inhibition of gene induction.

Conclusions/significance: These results indicate that inhibition of c-Jun by GSK-3 contributes to the repression of growth factor-inducible genes in quiescent cells. Together, AP-1, CREB and NFκB form an integrated transcriptional network that is largely responsible for maintaining repression of target genes downstream of GSK-3 signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Enzyme Stability / drug effects
  • Enzyme Stability / genetics
  • Gene Regulatory Networks* / drug effects
  • Gene Regulatory Networks* / genetics
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / metabolism*
  • Humans
  • Indoles / pharmacology
  • JNK Mitogen-Activated Protein Kinases / deficiency
  • JNK Mitogen-Activated Protein Kinases / genetics
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Maleimides / pharmacology
  • Mice
  • NF-kappa B / metabolism
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-jun / metabolism
  • RNA, Small Interfering / genetics
  • Resting Phase, Cell Cycle / drug effects
  • Resting Phase, Cell Cycle / genetics*
  • Transcription Factor AP-1 / metabolism*
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / genetics

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Indoles
  • JunD protein, human
  • Maleimides
  • NF-kappa B
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-jun
  • RNA, Small Interfering
  • SB 216763
  • Transcription Factor AP-1
  • JNK Mitogen-Activated Protein Kinases
  • Glycogen Synthase Kinase 3